Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-alpha-independent mechanism


Autoria(s): Allensworth, JL; Sauer, SJ; Lyerly, HK; Morse, MA; Devi, GR
Data(s)

01/01/2013

Formato

359 - 371

Identificador

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000313201100004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92

BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (2), pp. 359 - 371

0167-6806

http://hdl.handle.net/10161/12454

Relação

BREAST CANCER RESEARCH AND TREATMENT

10.1007/s10549-012-2352-6

Palavras-Chave #Smac/DIABLO #Inhibitor of apoptosis protein (IAP) #TRAIL #Inflammatory breast cancer (IBC) #TNF- alpha
Tipo

Journal Article